Monday, April 29, 2024
Zoetis to sell medicated feed additive portfolio to Phibro Animal Health
Zoetis Inc. and Phibro Animal Health Corporation announced on April 28 that they have entered into a definitive agreement where Phibro Animal Health will acquire Zoetis' medicated feed additive (MFA) product portfolio, certain water soluble ...
Wednesday, March 6, 2024
Zoetis expands operations with acquisition of manufacturing site in Australia
Animal health company Zoetis has acquired a 21-acre manufacturing site in Melbourne, Australia, signalling a significant expansion of its operations aimed at bolstering vaccine production for a range of animals including sheep and cattle, A ...
Tuesday, September 12, 2023
Zoetis Foundation announces US$2.6 million in grants to advance opportunities for livestock farmers and veterinarians
The Zoetis Foundation announced that it will distribute US$2.6 million during its second-round of 2023 grants, supporting six initiatives to help enable thriving professions and livelihoods for livestock farmers and veterinary professionals ...
Tuesday, August 29, 2023
Zoetis opens new diagnostics, biodevices R&D facility in Durham, North Carolina, US
Zoetis celebrated on August 24 the official opening of its new 78,000-square-foot building in Durham, North Carolina, the United States.
Tuesday, July 11, 2023
Zoetis announces appointment of new president of US operations
Zoetis Inc. has announced the addition of Ester Banque as executive vice president and president of US operations, effective July 10.
Friday, June 16, 2023
Zoetis releases 2022 Sustainability Report
Zoetis published its 2022 Sustainability Report, "Together We Are Making a Difference for a Better World", on June 15, describing the company's progress toward achieving its "Driven to Care" long-term sustainability aspi ...
Tuesday, March 14, 2023
Zoetis named one of the world's most ethical companies
Zoetis Inc. has been recognised by Ethisphere, a global leader in defining and advancing the standards of ethical business practices, as one of the 2023 World's Most Ethical Companies.
Monday, March 6, 2023
Zoetis secures grant to advance sustainable livestock production in Sub-Saharan Africa
Zoetis has received a US$15.3 million grant from the Bill & Melinda Gates Foundation to further develop and integrate innovative solutions to advance veterinary care and diagnostic services that will ultimately improve livestock health ...
Wednesday, February 1, 2023
Zoetis introduces mycoplasma hyopneumoniae management programme
Zoetis has introduced Mhp Guardian, the first comprehensive mycoplasma hyopneumoniae (Mhp) management programme that moves Mhp-positive swine herds into a negative or more stable status and keeps them there.
Tuesday, October 11, 2022
Zoetis named to Fortune's 2022 Change the World list
Zoetis has been named to Fortune's 2022 Change the World list, a global ranking of the top 50 companies making a positive social impact through business practices that are integral to their core corporate purpose.
Monday, October 3, 2022
Zoetis announces completion of acquisition of Jurox
Zoetis Inc. announced on September 30 it has completed the acquisition of Jurox, a privately held animal health company that develops, manufactures and markets a wide range of veterinary medicines for treating livestock and companion animal ...
Wednesday, August 24, 2022
Zoetis: Study shows genetically superior cows can be more sustainable and productive
A new study from Zoetis helps show the positive effect genetic selection in the dairy industry can have on environmental sustainability outcomes.
Wednesday, June 29, 2022
Zoetis celebrates progress toward better livestock health in Sub-Saharan Africa
Zoetis reported on June 28 on progress during the five years of its African Livestock Productivity and Health Advancement (ALPHA) initiative to establish sustainable veterinary care including access to vaccines, medicines and diagnostic ser ...
Monday, June 13, 2022
Zoetis releases 2021 sustainability update
Zoetis published on June 8 its 2021 Sustainability Progress Update describing the company's progress toward achieving its "Driven to Care" long-term sustainability aspirations and continued disclosure on environmental, social and ...
Thursday, June 9, 2022
Zoetis' bivalent vaccine outperformed monovalent vaccine amid emerging PCV2 variants
Zoetis Inc. announced on June 8 that new research recently published in the peer-reviewed journal Veterinary Research and shared at the American Association of Swine Veterinarians 2022 Annual Meeting shows that when compared to monovalent v ...

Follow Us